LESCHLY MARK
Insider CIK 1120545 · BFLY Director, 10% owner · ONTF 10% owner · ITEK 10% owner · RLOC 10% owner · NRX Director, 10% owner · CARA 10% owner · EVDY 10% owner · ANAC Director · NGM Director · IL 10% owner · CHPT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CHPT ChargePoint Holdings, Inc. | A Award | 2026-07-21 | 2026-07-22 | 18,370 | — | $0 | 39,745 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2026-07-21 | 2026-07-22 | 1,336 | — | $0 | 47,761 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2026-07-21 | 2026-07-22 | 6,680 | — | $0 | 46,425 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2025-07-08 | 2025-07-09 | 254,785 | — | $0 | 427,517 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2024-07-09 | 2024-07-11 | 115,552 | — | $0 | 172,732 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2023-07-18 | 2023-07-20 | 21,925 | — | $0 | 57,180 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2022-07-12 | 2022-07-14 | 13,563 | — | $0 | 35,255 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2021-07-12 | 2021-07-14 | 3,192 | — | $0 | 21,692 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | J Other | 2021-07-01 | 2021-07-02 | 12,650 | — | $0 | 420,946 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2021-06-08 | 2021-06-10 | 19,619 | — | $0 | 19,619 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2021-05-27 | 2021-06-01 | 18,500 | — | $0 | 18,500 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | J Other | 2021-03-19 | 2021-03-23 | 25,300 | — | $0 | 408,296 | SEC↗ |
| CHPT ChargePoint Holdings, Inc. | A Award | 2021-02-26 | 2021-03-02 | 382,996 | — | $0 | 382,996 | SEC↗ |
| ONTF ON24 INC. | C Conversion deriv | 2021-02-05 | 2021-02-08 | 3,364,868 | — | $0 | 0 | SEC↗ |
| ONTF ON24 INC. | C Conversion deriv | 2021-02-05 | 2021-02-08 | 567,991 | — | $0 | 0 | SEC↗ |
| ONTF ON24 INC. | S Sale | 2021-02-05 | 2021-02-08 | 294,965 | $50.00 | $14.75M | 3,637,894 | SEC↗ |
| ONTF ON24 INC. | C Conversion | 2021-02-05 | 2021-02-08 | 3,932,859 | — | $0 | 3,932,859 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2020-05-20 | 2020-05-22 | 16,806 | — | $0 | 16,806 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2019-05-15 | 2019-05-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion deriv | 2019-04-08 | 2019-04-10 | 600,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion deriv | 2019-04-08 | 2019-04-10 | 166,667 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion deriv | 2019-04-08 | 2019-04-10 | 3,000,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | C Conversion | 2019-04-08 | 2019-04-10 | 3,766,667 | — | $0 | 3,766,667 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2017-03-31 | 2017-04-03 | 500,000 | $18.19 | $9.10M | 3,568,057 | SEC↗ |
| IL IntraLinks Holdings, Inc. | U Tender | 2017-01-19 | 2017-01-19 | 6,290,503 | $13.00 | $81.78M | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | X Exercise deriv | 2016-12-05 | 2016-12-06 | 176,690 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | X Exercise | 2016-12-05 | 2016-12-06 | 176,690 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | U Tender | 2016-12-03 | 2016-12-06 | 4,397,630 | $10.50 | $46.18M | 176,690 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 24,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 4,096 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 794 | $99.25 | $78.8K | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2016-03-17 | 2016-03-18 | 247,727 | $4.93 | $1.22M | 3,068,057 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2016-03-16 | 2016-03-18 | 152,273 | $4.78 | $727.9K | 2,820,330 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-09-15 | 2015-09-16 | 11,793 | $9.34 | $110.1K | 3,846,702 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-09-14 | 2015-09-16 | 22,107 | $9.49 | $209.8K | 3,858,495 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-09-11 | 2015-09-14 | 17,333 | $9.49 | $164.5K | 3,880,602 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-09-10 | 2015-09-14 | 27,500 | $9.54 | $262.4K | 3,897,935 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-09-01 | 2015-09-01 | 42,983 | $9.97 | $428.5K | 3,925,435 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-08-29 | 2015-09-01 | 57,595 | $10.32 | $594.4K | 3,968,418 | SEC↗ |
| IL IntraLinks Holdings, Inc. | S Sale | 2015-08-28 | 2015-09-01 | 20,689 | $10.64 | $220.1K | 4,026,013 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-06-09 | 2015-06-11 | 4,096 | — | $0 | 4,096 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-06-09 | 2015-06-11 | 794 | — | $0 | 794 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 432,591 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 5,128,577 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | P Buy | 2015-02-23 | 2015-02-25 | 958,226 | $6.00 | $5.75M | 2,870,584 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 73,092 | — | $0 | 1,912,358 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 1,606,230 | — | $0 | 1,839,266 | SEC↗ |
| NRX NephroGenex, Inc. | S Sale | 2015-01-06 | 2015-01-06 | 20,941 | $9.90 | $207.3K | 1,052,966 | SEC↗ |
| NRX NephroGenex, Inc. | S Sale | 2015-01-05 | 2015-01-06 | 164,919 | $10.54 | $1.74M | 1,073,907 | SEC↗ |
| NRX NephroGenex, Inc. | S Sale | 2015-01-02 | 2015-01-06 | 88,000 | $10.83 | $953.0K | 1,238,826 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-08-27 | 2014-08-29 | 13,067 | $22.50 | $294.0K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-05-29 | 2014-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 384,874 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 1,970,210 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 393,060 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 861,110 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 1,646,948 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion deriv | 2014-04-02 | 2014-04-03 | 1,341,057 | — | $0 | 0 | SEC↗ |
| EVDY Everyday Health, Inc. | S Sale | 2014-04-02 | 2014-04-03 | 92,120 | $13.02 | $1.20M | 6,000,957 | SEC↗ |
| EVDY Everyday Health, Inc. | C Conversion | 2014-04-02 | 2014-04-03 | 4,554,808 | — | $0 | 6,093,077 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 106,697 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 1,215,268 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 5,631,531 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 494,447 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 1,215,268 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion deriv | 2014-02-14 | 2014-02-19 | 106,697 | — | $0 | 0 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 203,374 | — | $0 | 1,145,829 | SEC↗ |
| NRX NephroGenex, Inc. | A Award | 2014-02-14 | 2014-02-19 | 180,997 | — | $0 | 1,326,826 | SEC↗ |
| NRX NephroGenex, Inc. | C Conversion | 2014-02-14 | 2014-02-19 | 942,455 | — | $0 | 942,455 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion deriv | 2014-02-05 | 2014-02-05 | 6,105,598 | — | $0 | 0 | SEC↗ |
| CARA Cara Therapeutics, Inc. | C Conversion | 2014-02-05 | 2014-02-05 | 2,442,239 | — | $0 | 2,442,239 | SEC↗ |
| CARA Cara Therapeutics, Inc. | P Buy | 2014-02-05 | 2014-02-05 | 225,818 | $11.00 | $2.48M | 2,668,057 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | J Other | 2014-02-03 | 2014-06-06 | 13,067 | — | $0 | 13,067 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-06-06 | 2013-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BFLY BLUEFLY INC | J Other deriv | 2013-05-23 | 2013-05-28 | 0 | — | $0 | 0 | SEC↗ |
| BFLY BLUEFLY INC | J Other | 2013-05-23 | 2013-05-28 | 1,875 | — | $0 | 0 | SEC↗ |
| BFLY BLUEFLY INC | S Sale | 2013-05-23 | 2013-05-28 | 11,900,164 | $0.01 | $119.0K | 0 | SEC↗ |
| RLOC ReachLocal Inc | S Sale | 2012-11-28 | 2012-11-30 | 275,000 | $11.16 | $3.07M | 2,756,966 | SEC↗ |
| BFLY BLUEFLY INC | P Buy | 2012-11-13 | 2012-11-15 | 298,858 | $1.00 | $298.9K | 11,900,164 | SEC↗ |
| BFLY BLUEFLY INC | A Award deriv | 2012-08-13 | 2012-08-15 | 476,190 | $1.05 | $500.0K | 476,190 | SEC↗ |
| BFLY BLUEFLY INC | A Award deriv | 2012-08-13 | 2012-08-15 | 0 | — | $0 | 0 | SEC↗ |
| RLOC ReachLocal Inc | S Sale | 2012-08-08 | 2012-08-08 | 50,000 | $12.84 | $642.0K | 3,031,966 | SEC↗ |
| RLOC ReachLocal Inc | S Sale | 2012-08-07 | 2012-08-08 | 181,707 | $12.81 | $2.33M | 3,081,966 | SEC↗ |
| RLOC ReachLocal Inc | S Sale | 2012-08-06 | 2012-08-08 | 68,293 | $12.78 | $872.8K | 3,263,673 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-05-30 | 2012-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |